1 completed, 1 withdrawn. 1 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Withdrawn 1 |
Follow Hydroxyzine HCL: new trials by email Literature Review of Hydroxyzine HCL trials Research Report on Hydroxyzine HCL
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| E7 TCR T Cells for Human Papillomavirus-Associated Cancers E7 TCR cells, Aldesleukin, Fludarabine - Papillomavirus Infections, Cervical Intraepithelial Neoplasia | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 224 | 2017-01-27 | 2026-03-09 |
| Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder Hydroxyzine, hydroxyzine HCL, Placebo - Anxiety in Those Patients With Anorexia Nervosa, Eating Disorder Not Otherwise Specified, BMI (<=18) | Phase 4 | Withdrawn | HealthPartners Institute | 2012-01-01 | 2016-11-15 |
Carcinoma in Situ (1) · Papillomavirus Infections (1) · Uterine Cervical Dysplasia (1) · Vulvar Diseases (1) · Vulvar Neoplasms (1)
HealthPartners Institute (1) · National Cancer Institute (NCI) (1)
United States (2)
Marcus Westerman, MD, PhD (1) · Scott M Norberg, D.O. (1)